Expressing the sense of Congress to encourage full participation of Taiwan in the Asia-Pacific Economic Cooperation forum.
- Last Action
- 10/25/2023
Actions
- 2023-01-09Referred to the House Committee on Energy and Commerce.
- 2023-01-09Referred to the Subcommittee on Health.
- 2023-01-09Introduced in House
- 2023-01-09Introduced in House
CRS Summary
As of 2023-01-09 (00)
Medical Innovation Acceleration Act of 2023
This bill exempts noninvasive diagnostic devices from the regulatory authority of the Food and Drug Administration.
The bill defines noninvasive diagnostic device as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.
Subjects
- Administrative remedies
- Drug safety, medical device, and laboratory regulation
- Food and Drug Administration (FDA)
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.